RNS Number : 3373G
GlaxoSmithKline PLC
23 July 2021
GlaxoSmithKline plc
Board Committee Changes
GlaxoSmithKline plc today announces the following change to its Board Committee membership effective 23 July 2021.
Dr Anne Beal has been appointed a member of the Audit & Risk Committee. This appointment is in addition to her membership of the Corporate Responsibility Committee.
V A Whyte
Company Secretary
23 July 2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
